Recall Record

East Windsor, NJ, United States

Novitium Pharma LLC recalls

3 recalls recorded since 2018, most recently on 25 March 2024. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0

Terminated Class III Drugs

Recall started
25 March 2024
Terminated
16 July 2024
Reason
Failed Impurities/Degradation Specifications
Distribution
U.S. Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0443-2024

Terminated Class III Drugs

Recall started
4 March 2024
Terminated
21 March 2025
Reason
Cross Contamination with Other Products:(mycophenolate mofetil).
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0389-2024

Terminated Class II Drugs

Recall started
25 October 2019
Terminated
17 March 2021
Reason
CGMP Deviations: Presence of NDMA impurity detected in product.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0311-2020, D-0310-2020, D-0312-2020, D-0313-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.